Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_04-cv-03732/USCOURTS-cand-3_04-cv-03732-52/pdf.json

Parties Involved:
Abbott Laboratories
Counter-defendant
Nova Biomedical Corporation
Counter-claimant
Therasense, Inc.
Counter-defendant

Document Text:

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

THERASENSE, INC.,

Plaintiff,

 v.

BECTON, DICKINSON AND COMPANY,

Defendant. /

BECTON DICKINSON & COMPANY

AND ABBOTT LABORATORIES,

Plaintiffs, 

 v.

THERASENSE, INC.,

Defendant. /

THERASENSE, INC., AND ABBOTT

LABORATORIES, 

Plaintiffs, 

 v.

NOVA BIOMEDICAL CORPORATION,

Defendant. / 

No. C 04-02123 WHA

No. C 04-03327 WHA

No. C 04-03732 WHA

No. C 05-03117 WHA

CONSOLIDATION ORDER,

TRIAL SCHEDULING ORDER

AND ORDER OF REFERENCE

TO MAGISTRATE JUDGE FOR

MEDIATION/SETTLEMENT

Case 3:04-cv-03732-WHA Document 351 Filed 04/11/08 Page 1 of 3
United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

ABBOTT DIABETES CARE, INC., AND

ABBOTT LABORATORIES, 

Plaintiffs, 

 v.

ROCHE DIAGNOSTICS CORPORATION

AND BAYER HEALTHCARE, LLC,

Defendants. /

These cases were previously set for trial three times before Judge Jenkins but the last

date was recently vacated in light of his impending departure from the federal bench to join the

state appellate court. All of them have now been re-assigned to the undersigned. The cases

should be ready for trial after numerous summary judgment motions and decisions thereon by

Judge Jenkins. 

The above-entitled civil actions are hereby provisionally CONSOLIDATED for trial

subject to bifurcation motion practice to be heard and decided at the final pretrial conference.

The bifurcation motions shall be briefed on the schedule below. Trial is set for 7:30 A.M. ON

TUESDAY, MAY 27, 2008. The final pretrial conference is set for 8:00 A.M. ON WEDNESDAY,

MAY 21, 2008. All parties and counsel must be prepared to proceed as scheduled and should

not await the outcome of motion practice to prepare for trial. 

By APRIL 21, 2008, AT NOON, each accused infringer may file up to three

motions in limine, each limited to ten pages (regular font) with the minimum declarations and

exhibits needed for a ruling, each limited to one matter (e.g., challenging an expert’s

methodology for a certain finding). By MAY 5, AT NOON, the other side must respond,

each memo limited to ten pages with the minimum declarations and exhibits needed for a ruling. 

Replies are not needed but if filed must be very short with no further evidentiary material absent

exceedingly good cause and will be due MAY 9, AT NOON. Therasense-Abbott may file up to

six motions in limine, divided as it wishes, among the various accused infringers, all to be

briefed on the same schedule as above. These will all be considered at the final pretrial

conference. Please tab all exhibits. This is without prejudice to other motions in limine that can

Case 3:04-cv-03732-WHA Document 351 Filed 04/11/08 Page 2 of 3
United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

3

be heard as the trial progresses, so the foregoing motions should be directed only to those issues

needing a ruling before trial begins. However, in the final pretrial statement, please briefly

describe (three to four lines) each other motion in limine counsel would like to present. 

This also is without prejudice to raising issues as the trial progresses. 

Dr. Hill may be deposed on the conditions set at the hearing. All other witnesses seem

to have fixable schedule problems. 

Except to the extent modified above for motions in limine, please follow the

undersigned’s “Guidelines for Trial and Final Pretrial Conference in Civil Jury Cases,”

available on the district court website. All exhibits and other designations must be made timely

for the May 21 conference even as to matters that will trail. 

Bayer, Roche and BD/Nova may file the summary judgment motions specifically

described in the April 10 filing, to be briefed as follows: 

Opening: Noon, April 21, 2008

Opposition: Noon, May 5, 2008

Reply: Noon, May 9, 2008

HEARING: 8:00 A.M., MAY 21, 2008

Please honor the fifteen-page limits promised. If the motions are not as straightforward and

short as promised, they will likely be denied. Do not simply make a beefed up version of the

theories already presented to Judge Jenkins. Plaintiff may bring its two motions for

reconsideration on the same schedule. If plaintiff is going to narrow the claims and withdraw

claims, please do so in writing by MAY 5, 2008. 

The BD/Nova portion of the case is REFERRED to MAGISTRATE JUDGE ELIZABETH

LAPORTE for MEDIATION/SETTLEMENT.

IT IS SO ORDERED.

Dated: April 11, 2008. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:04-cv-03732-WHA Document 351 Filed 04/11/08 Page 3 of 3